Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
About this item
Full title
Author / Creator
Publisher
Boston: Boston : Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Boston : Springer US
Subjects
More information
Scope and Contents
Contents
Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common treatable acquired chronic polyneuropathy. Corticosteroids, plasmapheresis and intravenous immunoglobulins (IVIG) have been shown to be effective in randomized controlled clinical trials and IVIG is widely used as a first-line initial and maintenance treatment fo...
Alternative Titles
Full title
Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733344637
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733344637
Other Identifiers
ISSN
0271-9142
E-ISSN
1573-2592
DOI
10.1007/s10875-010-9398-1
